1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesNutritional and Metabolic Diseases, central nervous system disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, injury, metabolic disease, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury, type 2 diabetes mellitusRecruitingPhase 42026-10-05NCT06706284